Related Experiment Video
Updated: Jan 18, 2026

Inducement and Evaluation of a Murine Model of Experimental Myopia
Published on: January 22, 2019
Does Past Myopia Progression Predict Future Progression?
Wesley T Beaulieu1, Michael X Repka2, Stacy L Pineles3
1Jaeb Center for Health Research, Tampa, Florida, United States.
Insights
Prior changes in spherical equivalent refractive error (SER) and axial length (AL) poorly predict future myopia progression in children. These metrics have limited clinical utility for decision-making or trial participant selection.
Area of Science:
- Ophthalmology
- Pediatric Optometry
- Myopia Research
Background:
- Myopia progression is a significant concern in pediatric eye care.
- Accurate prediction of myopia progression is crucial for timely intervention.
- Previous refractive error and axial length changes are potential indicators of future progression.
Purpose of the Study:
- To evaluate the predictive value of prior changes in spherical equivalent refractive error (SER) and axial length (AL) for future myopia progression in children.
- To quantify the accuracy of using past SER and AL measurements to forecast subsequent myopia development.
Main Methods:
- A post hoc analysis of a randomized controlled trial involving children aged 5-12 years.
- Data from 136 children with myopia (SER -1.00 to -6.00 D) treated with 0.01% atropine or placebo for 24 months were analyzed.
- Multivariable linear regression assessed the association between SER/AL changes over the first 12 months and the subsequent 12 months.
Main Results:
- The positive predictive value of a 0.50-D SER increase in predicting a similar increase later was only 42%.
- Prior 12-month SER change showed a weak association with subsequent SER change (0.20 D per 1.00 D increase).
- Prediction intervals for future progression were negligibly improved by including prior changes in SER and AL.
Conclusions:
- Changes in SER and AL over a 12-month period are poor predictors of future myopia progression in children.
- These findings suggest limited clinical utility for using prior refractive error and axial length changes in myopia management decisions.
- The predictive value is insufficient for reliably selecting participants for myopia control clinical trials.
Purpose:
To quantify the value of using prior changes in spherical equivalent refractive error (SER) and axial length (AL) to predict future myopia progression.
Methods:
For this post hoc analysis of a randomized controlled trial, we used data from children ages 5 to 12 years with SER -1.00 to -6.00 D who had been randomized 2:1 to 0.01% atropine or placebo eye drops for 24 months. Multivariable linear regression evaluated the association of baseline-to-12-month change in SER and AL versus 12-to-24-month change while controlling for age and SER or AL at 12 months. Treatment groups were pooled for analyses; sensitivity analyses were conducted using only the placebo group.
Results:
Among 187 children, 136 (73%) with complete data were included. For predicting a 0.50-D-or-more SER increase of myopia in the second 12 months based on observing a 0.50-D-or-more increase of myopia in the first 12 months, the positive predictive value was 42% (19 of 45; 95% confidence interval [CI], 29%-57%). Greater baseline-to-12-month SER change was weakly associated with greater 12-to-24-month SER change (0.20 D per additional 1.00 D; 95% CI, 0.02 to 0.39; P = 0.03; partial R2 = 0.03). The 95% prediction interval half-width for 12-to-24-month change was ±0.66 D with prior change versus ±0.67 D without (difference = 0.01 D; 95% CI, -0.05 to 0.07). Analyses of AL and sensitivity analyses limited to the placebo group were qualitatively similar.
Conclusions:
Changes in SER and AL of children in the prior 12 months were poor predictors of future myopia progression, limiting their usefulness for clinical decision-making or selecting participants for clinical trials.
Related Concept Videos
Focusing of Light in the Eye
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

